enGene Therapeutics ENGN
NASDAQ ENGN
$1.56 -0.02 (-1.27%)
At close: Oct 23, 2026 · 4:00 PM EDT

enGene Therapeutics (ENGN) Purchase of Investments (2025 - 2026)

Updated

Analysis

enGene Therapeutics (ENGN) Purchase of Investments (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Purchased (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 307.00 Mn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 919.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 834.00 Mn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 148.00 Mn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 46.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 42.00 Mn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.54 Bn
10 enGene Therapeutics 104.54 Mn -889.93 Mn - 42.38 Mn
Historic Data

Historic Data

Download Data
DateValue
Jul 31, 2026 42.38 Mn
Apr 30, 2026 50.21 Mn
Jan 31, 2026 169.19 Mn
Oct 31, 2025 7.75 Mn
Jul 31, 2025 44.67 Mn
Apr 30, 2025 13.76 Mn
Jan 31, 2025 94.67 Mn
API Access

enGene Therapeutics Purchase of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=purchase-of-investments&ticker=ENGN&period=max&api_key=YOUR_API_KEY